Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 69.30
-0.70 (-1.00%)
At close: Dec 29, 2025
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.58 billion as of December 31, 2025. Its market cap has increased by 111.08% in one year.
Market Cap
3.58B
Enterprise Value
3.19B
Revenue
159.02M
Ranking
n/a
PE Ratio
170.78
Stock Price
69.30
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.58B, an increase of 157.48%. That is a compound annual growth rate of 93.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 40.20T |
| Hon Hai Precision Industry | 3.22T |
| Delta Electronics | 2.50T |
| MediaTek | 2.28T |
| Fubon Financial Holding | 1.31T |
| Cathay Financial Holding | 1.11T |
| ASE Technology Holding | 1.09T |
| Quanta Computer | 1.05T |